Stephens Investment Management Group LLC Has $57.21 Million Holdings in HealthEquity, Inc. $HQY

Stephens Investment Management Group LLC decreased its stake in shares of HealthEquity, Inc. (NASDAQ:HQY) by 5.7% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 684,619 shares of the company’s stock after selling 41,566 shares during the period. Stephens Investment Management Group LLC’s holdings in HealthEquity were worth $57,214,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also made changes to their positions in HQY. Fifth Third Wealth Advisors LLC lifted its position in HealthEquity by 4.2% in the 1st quarter. Fifth Third Wealth Advisors LLC now owns 2,872 shares of the company’s stock valued at $240,000 after acquiring an additional 116 shares in the last quarter. Truist Financial Corp increased its holdings in HealthEquity by 4.9% during the 4th quarter. Truist Financial Corp now owns 2,537 shares of the company’s stock worth $232,000 after purchasing an additional 119 shares in the last quarter. Fiduciary Trust Co increased its holdings in HealthEquity by 3.4% during the 3rd quarter. Fiduciary Trust Co now owns 3,669 shares of the company’s stock worth $348,000 after purchasing an additional 120 shares in the last quarter. Larson Financial Group LLC raised its stake in shares of HealthEquity by 24.4% in the 3rd quarter. Larson Financial Group LLC now owns 628 shares of the company’s stock valued at $60,000 after purchasing an additional 123 shares during the period. Finally, GAMMA Investing LLC raised its stake in shares of HealthEquity by 9.5% in the 4th quarter. GAMMA Investing LLC now owns 1,944 shares of the company’s stock valued at $178,000 after purchasing an additional 168 shares during the period. 99.55% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at HealthEquity

In other news, EVP Michael Henry Fiore sold 3,142 shares of the company’s stock in a transaction that occurred on Friday, May 29th. The stock was sold at an average price of $95.00, for a total transaction of $298,490.00. Following the sale, the executive vice president owned 59,113 shares in the company, valued at $5,615,735. This represents a 5.05% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Delano Ladd sold 7,500 shares of the firm’s stock in a transaction on Thursday, May 28th. The shares were sold at an average price of $90.00, for a total transaction of $675,000.00. Following the completion of the transaction, the executive vice president directly owned 91,141 shares of the company’s stock, valued at $8,202,690. This represents a 7.60% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 13,081 shares of company stock worth $1,193,000 in the last 90 days. Corporate insiders own 1.60% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on the company. Citigroup reaffirmed a “market outperform” rating on shares of HealthEquity in a research report on Monday, June 1st. Weiss Ratings upgraded HealthEquity from a “hold (c)” rating to a “hold (c+)” rating in a research note on Friday, June 5th. KeyCorp reaffirmed an “overweight” rating on shares of HealthEquity in a research report on Tuesday, May 26th. Deutsche Bank Aktiengesellschaft raised their price target on shares of HealthEquity from $120.00 to $128.00 and gave the stock a “buy” rating in a research note on Thursday, March 19th. Finally, Citizens Jmp boosted their price objective on shares of HealthEquity from $110.00 to $111.00 and gave the stock a “market outperform” rating in a research report on Monday, June 1st. One investment analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating, one has given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, HealthEquity presently has a consensus rating of “Moderate Buy” and an average price target of $110.57.

HealthEquity Price Performance

Shares of NASDAQ HQY opened at $95.31 on Friday. The company has a debt-to-equity ratio of 0.46, a current ratio of 3.44 and a quick ratio of 3.44. The business has a 50-day moving average of $86.04 and a 200-day moving average of $84.67. The stock has a market capitalization of $7.97 billion, a price-to-earnings ratio of 35.70, a PEG ratio of 1.60 and a beta of 0.21. HealthEquity, Inc. has a fifty-two week low of $72.76 and a fifty-two week high of $105.96.

HealthEquity (NASDAQ:HQY) last released its earnings results on Thursday, May 28th. The company reported $1.24 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.11 by $0.13. HealthEquity had a return on equity of 14.75% and a net margin of 17.25%.The business had revenue of $354.64 million for the quarter, compared to analyst estimates of $352.02 million. The company’s revenue was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. As a group, sell-side analysts predict that HealthEquity, Inc. will post 3.92 earnings per share for the current fiscal year.

HealthEquity Company Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.